Serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease.

Neurol Neuroimmunol Neuroinflamm

From the Department of Neurology (H.K., E.-J.L., S.K., L.-K.C., K.K., H.W.K., K.-K.K., Y.-M.L.) and Asan Medical Institute of Convergence Science and Technology (E.-J.L., S.K.), Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Published: May 2020

Objective: To test the hypothesis that the pattern of serum biomarkers of disease activity and disability in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) will be different from those in neuromyelitis optica spectrum disorder (NMOSD) with anti-aquaporin-4 antibodies (AQP4-Abs).

Methods: Using ultrasensitive single-molecule array assays, we measured neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), and tau in the sera of consecutive patients with MOGAD (n = 16) and NMOSD with AQP4-Ab (n = 33). Serum biomarker levels were compared between patients in relapse and remission states, and correlations between the levels of these biomarkers and Expanded Disability Status Scale (EDSS) scores were analyzed within each group.

Results: In the MOGAD group, the serum tau level was higher in a relapse state than in a remission state (relapse vs remission: 0.5 [0.4-0.5] vs 0.2 [0.1-0.3] pg/mL, = 0.027). Both serum levels of NfL and tau correlated with the EDSS score (NfL: r = 0.684, = 0.003; tau: r = 0.524, = 0.045). Meanwhile, in the NMOSD group, serum NfL and GFAP levels were higher in a relapse state than in a remission state (relapse vs remission: NfL, 34.8 [12.2-62.3] vs 13.0 [11.3-20.0] pg/mL, = 0.010; GFAP, 253.8 [150.6-303.0] vs 104.4 [93.9-127.9] pg/mL, = 0.016). Only the serum GFAP level correlated with the EDSS score (r = 0.485, = 0.012).

Conclusion: The pattern of serum biomarkers of disease activity and disability in MOGAD showed a distinct feature from those in NMOSD with AQP4-Ab, which implicates different pathogeneses between the 2 diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136043PMC
http://dx.doi.org/10.1212/NXI.0000000000000708DOI Listing

Publication Analysis

Top Keywords

serum biomarkers
12
relapse remission
12
serum
8
myelin oligodendrocyte
8
oligodendrocyte glycoprotein
8
glycoprotein antibody-associated
8
antibody-associated disease
8
pattern serum
8
biomarkers disease
8
disease activity
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!